Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gynecologic Surgical Procedures | 6 | 2025 | 66 | 2.090 |
Why?
|
| Pelvic Floor Disorders | 5 | 2025 | 12 | 1.480 |
Why?
|
| Pelvic Organ Prolapse | 7 | 2025 | 29 | 1.230 |
Why?
|
| Lacerations | 2 | 2019 | 31 | 1.110 |
Why?
|
| Obstetric Labor Complications | 3 | 2024 | 93 | 1.110 |
Why?
|
| Delivery, Obstetric | 4 | 2024 | 255 | 0.860 |
Why?
|
| Anal Canal | 3 | 2019 | 85 | 0.840 |
Why?
|
| Vagina | 6 | 2023 | 200 | 0.830 |
Why?
|
| Laparoscopy | 4 | 2022 | 541 | 0.690 |
Why?
|
| Robotic Surgical Procedures | 2 | 2022 | 224 | 0.640 |
Why?
|
| Dilatation | 2 | 2024 | 66 | 0.590 |
Why?
|
| Simulation Training | 1 | 2022 | 168 | 0.580 |
Why?
|
| Documentation | 1 | 2019 | 120 | 0.540 |
Why?
|
| Gynecology | 4 | 2025 | 127 | 0.520 |
Why?
|
| Obstetrics | 4 | 2025 | 241 | 0.500 |
Why?
|
| Supreme Court Decisions | 2 | 2025 | 16 | 0.440 |
Why?
|
| Pregnancy Complications | 2 | 2010 | 540 | 0.420 |
Why?
|
| Urinary Retention | 2 | 2025 | 19 | 0.400 |
Why?
|
| Pelvic Floor | 3 | 2024 | 36 | 0.380 |
Why?
|
| Quality Improvement | 1 | 2019 | 699 | 0.380 |
Why?
|
| Emotional Intelligence | 1 | 2012 | 15 | 0.370 |
Why?
|
| Achievement | 1 | 2012 | 32 | 0.370 |
Why?
|
| Labor Pain | 1 | 2012 | 3 | 0.370 |
Why?
|
| Perineum | 2 | 2025 | 40 | 0.360 |
Why?
|
| Analgesia, Epidural | 1 | 2012 | 31 | 0.360 |
Why?
|
| Valsalva Maneuver | 1 | 2011 | 8 | 0.350 |
Why?
|
| Labor, Obstetric | 1 | 2012 | 93 | 0.350 |
Why?
|
| Patient Admission | 1 | 2012 | 184 | 0.330 |
Why?
|
| Cardiotocography | 1 | 2010 | 19 | 0.310 |
Why?
|
| Female | 31 | 2025 | 70560 | 0.300 |
Why?
|
| Intraoperative Care | 1 | 2010 | 122 | 0.300 |
Why?
|
| Healthcare Disparities | 2 | 2025 | 507 | 0.300 |
Why?
|
| Computer Simulation | 2 | 2022 | 678 | 0.290 |
Why?
|
| Abdomen, Acute | 1 | 2008 | 13 | 0.290 |
Why?
|
| Pregnancy | 9 | 2024 | 7402 | 0.290 |
Why?
|
| Patient Education as Topic | 1 | 2012 | 458 | 0.280 |
Why?
|
| Internship and Residency | 4 | 2025 | 1216 | 0.270 |
Why?
|
| Parturition | 2 | 2018 | 63 | 0.260 |
Why?
|
| Health Services Accessibility | 2 | 2025 | 694 | 0.260 |
Why?
|
| Uterine Prolapse | 1 | 2025 | 22 | 0.230 |
Why?
|
| Humans | 38 | 2025 | 130870 | 0.230 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 63 | 0.220 |
Why?
|
| Endometrial Hyperplasia | 1 | 2005 | 21 | 0.220 |
Why?
|
| Salpingectomy | 2 | 2016 | 15 | 0.220 |
Why?
|
| Adult | 18 | 2025 | 31245 | 0.220 |
Why?
|
| Prospective Studies | 7 | 2022 | 6450 | 0.210 |
Why?
|
| Endometrial Neoplasms | 1 | 2005 | 109 | 0.200 |
Why?
|
| Menopause | 1 | 2023 | 86 | 0.190 |
Why?
|
| Hysterectomy | 3 | 2023 | 199 | 0.190 |
Why?
|
| Suture Techniques | 3 | 2019 | 175 | 0.190 |
Why?
|
| Hyaluronic Acid | 1 | 2023 | 108 | 0.190 |
Why?
|
| Surgical Mesh | 1 | 2022 | 64 | 0.180 |
Why?
|
| Urinary Incontinence | 1 | 2022 | 69 | 0.180 |
Why?
|
| Receptors, Progesterone | 1 | 2005 | 676 | 0.170 |
Why?
|
| Receptors, Estrogen | 1 | 2005 | 735 | 0.170 |
Why?
|
| Surveys and Questionnaires | 7 | 2025 | 4017 | 0.160 |
Why?
|
| Medicare | 1 | 2023 | 438 | 0.160 |
Why?
|
| Hospitals, Private | 1 | 2019 | 22 | 0.150 |
Why?
|
| Sperm Count | 2 | 1998 | 100 | 0.150 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 1269 | 0.140 |
Why?
|
| Motor Neurons | 1 | 2019 | 137 | 0.140 |
Why?
|
| Ileum | 1 | 2019 | 109 | 0.140 |
Why?
|
| Rupture | 1 | 2018 | 33 | 0.140 |
Why?
|
| Rectum | 1 | 2019 | 102 | 0.140 |
Why?
|
| Colectomy | 1 | 2019 | 90 | 0.140 |
Why?
|
| Pilot Projects | 2 | 2024 | 1457 | 0.140 |
Why?
|
| Labor Stage, First | 1 | 2017 | 8 | 0.140 |
Why?
|
| Safety-net Providers | 1 | 2019 | 86 | 0.140 |
Why?
|
| Elasticity | 1 | 2018 | 94 | 0.140 |
Why?
|
| Constipation | 1 | 2019 | 127 | 0.130 |
Why?
|
| Action Potentials | 1 | 2019 | 473 | 0.120 |
Why?
|
| Ovariectomy | 1 | 2016 | 157 | 0.120 |
Why?
|
| Middle Aged | 11 | 2025 | 28517 | 0.120 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2016 | 29 | 0.120 |
Why?
|
| Mothers | 1 | 2018 | 369 | 0.110 |
Why?
|
| Feasibility Studies | 1 | 2018 | 813 | 0.110 |
Why?
|
| Retrospective Studies | 8 | 2025 | 17673 | 0.110 |
Why?
|
| Young Adult | 3 | 2024 | 10042 | 0.110 |
Why?
|
| Suburethral Slings | 1 | 2014 | 9 | 0.100 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2014 | 32 | 0.100 |
Why?
|
| Urethra | 1 | 2014 | 58 | 0.100 |
Why?
|
| Ultrasonography | 2 | 2024 | 968 | 0.100 |
Why?
|
| United States | 5 | 2025 | 11865 | 0.100 |
Why?
|
| Quality of Life | 1 | 2023 | 2082 | 0.100 |
Why?
|
| Organization and Administration | 1 | 2012 | 4 | 0.100 |
Why?
|
| Models, Biological | 1 | 2017 | 1391 | 0.090 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 434 | 0.090 |
Why?
|
| Aged | 8 | 2025 | 20974 | 0.090 |
Why?
|
| Cultural Characteristics | 1 | 2012 | 45 | 0.090 |
Why?
|
| Electronic Health Records | 1 | 2019 | 818 | 0.090 |
Why?
|
| Acculturation | 1 | 2012 | 60 | 0.090 |
Why?
|
| Aging | 1 | 2019 | 1257 | 0.090 |
Why?
|
| Cultural Competency | 1 | 2012 | 51 | 0.090 |
Why?
|
| Treatment Outcome | 4 | 2022 | 12914 | 0.080 |
Why?
|
| Vulvar Diseases | 1 | 2010 | 13 | 0.080 |
Why?
|
| Phosphodiesterase Inhibitors | 2 | 2000 | 54 | 0.080 |
Why?
|
| Prenatal Care | 1 | 2012 | 341 | 0.070 |
Why?
|
| Canada | 1 | 2010 | 323 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 376 | 0.070 |
Why?
|
| Radiation, Ionizing | 1 | 2008 | 38 | 0.070 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 3807 | 0.070 |
Why?
|
| Abscess | 1 | 2010 | 136 | 0.070 |
Why?
|
| Biliary Tract Diseases | 1 | 2008 | 33 | 0.070 |
Why?
|
| Piperazines | 2 | 2000 | 270 | 0.070 |
Why?
|
| Safety | 1 | 2008 | 215 | 0.070 |
Why?
|
| Pancreatitis | 1 | 2008 | 137 | 0.070 |
Why?
|
| Erectile Dysfunction | 2 | 2000 | 195 | 0.060 |
Why?
|
| Appendicitis | 1 | 2008 | 132 | 0.060 |
Why?
|
| Internet | 1 | 2010 | 420 | 0.060 |
Why?
|
| Cyclooxygenase 2 | 1 | 2005 | 121 | 0.050 |
Why?
|
| Parity | 1 | 2024 | 78 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 1125 | 0.050 |
Why?
|
| Accreditation | 1 | 2024 | 87 | 0.050 |
Why?
|
| Hysterectomy, Vaginal | 1 | 2023 | 19 | 0.050 |
Why?
|
| Dehydroepiandrosterone | 1 | 2023 | 24 | 0.050 |
Why?
|
| Women's Health | 1 | 2024 | 131 | 0.050 |
Why?
|
| Prolapse | 1 | 2022 | 10 | 0.050 |
Why?
|
| Clinical Competence | 2 | 2024 | 1055 | 0.050 |
Why?
|
| Endometrium | 1 | 2005 | 283 | 0.050 |
Why?
|
| Tamoxifen | 1 | 2023 | 349 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1612 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2025 | 699 | 0.040 |
Why?
|
| Time Factors | 1 | 2011 | 6217 | 0.040 |
Why?
|
| Private Sector | 1 | 2021 | 26 | 0.040 |
Why?
|
| Appointments and Schedules | 1 | 2021 | 48 | 0.040 |
Why?
|
| Estrogens | 1 | 2023 | 430 | 0.040 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2023 | 222 | 0.040 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2021 | 72 | 0.040 |
Why?
|
| Hospitals, Public | 1 | 2021 | 49 | 0.040 |
Why?
|
| Medically Uninsured | 1 | 2021 | 78 | 0.040 |
Why?
|
| Adolescent | 1 | 2019 | 20820 | 0.040 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2000 | 50 | 0.040 |
Why?
|
| Urology | 1 | 2021 | 80 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2025 | 702 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2021 | 352 | 0.040 |
Why?
|
| Defecography | 1 | 2019 | 2 | 0.040 |
Why?
|
| Psychometrics | 1 | 2023 | 671 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2024 | 551 | 0.040 |
Why?
|
| Gastrointestinal Transit | 1 | 2019 | 28 | 0.040 |
Why?
|
| Spermatogenesis | 1 | 2000 | 168 | 0.040 |
Why?
|
| Ambulatory Care Facilities | 1 | 2021 | 233 | 0.040 |
Why?
|
| Muscle Contraction | 1 | 2019 | 146 | 0.040 |
Why?
|
| Vasovasostomy | 1 | 1998 | 22 | 0.040 |
Why?
|
| Electromyography | 1 | 2019 | 139 | 0.040 |
Why?
|
| Oligospermia | 1 | 1998 | 65 | 0.040 |
Why?
|
| Sacrum | 1 | 2018 | 27 | 0.040 |
Why?
|
| Male | 9 | 2025 | 64772 | 0.040 |
Why?
|
| Microsurgery | 1 | 1998 | 65 | 0.030 |
Why?
|
| Viscosity | 1 | 2018 | 37 | 0.030 |
Why?
|
| Geography | 1 | 1998 | 116 | 0.030 |
Why?
|
| Prostatectomy | 1 | 1999 | 300 | 0.030 |
Why?
|
| Anastomosis, Surgical | 1 | 2019 | 176 | 0.030 |
Why?
|
| Epididymis | 1 | 1998 | 64 | 0.030 |
Why?
|
| Testis | 1 | 2000 | 397 | 0.030 |
Why?
|
| Testosterone | 1 | 2023 | 593 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2005 | 1605 | 0.030 |
Why?
|
| Infertility, Male | 1 | 2000 | 296 | 0.030 |
Why?
|
| Spinal Cord Injuries | 1 | 2000 | 273 | 0.030 |
Why?
|
| Organ Sparing Treatments | 1 | 2016 | 38 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 2925 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 680 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 912 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2019 | 1238 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 1009 | 0.020 |
Why?
|
| Patient Selection | 1 | 2016 | 723 | 0.020 |
Why?
|
| Texas | 1 | 2021 | 3635 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2014 | 482 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2014 | 1215 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 2112 | 0.020 |
Why?
|
| Sildenafil Citrate | 2 | 2000 | 56 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2022 | 3131 | 0.020 |
Why?
|
| Sulfones | 2 | 2000 | 72 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 2842 | 0.020 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2010 | 32 | 0.020 |
Why?
|
| Cellulitis | 1 | 2010 | 62 | 0.020 |
Why?
|
| Purines | 2 | 2000 | 115 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2010 | 197 | 0.020 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 230 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 6801 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2016 | 3694 | 0.020 |
Why?
|
| Reoperation | 1 | 2010 | 834 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2010 | 563 | 0.010 |
Why?
|
| Length of Stay | 1 | 2010 | 1396 | 0.010 |
Why?
|
| Flushing | 1 | 2000 | 6 | 0.010 |
Why?
|
| Dizziness | 1 | 2000 | 18 | 0.010 |
Why?
|
| Ejaculation | 1 | 2000 | 19 | 0.010 |
Why?
|
| Headache | 1 | 2000 | 109 | 0.010 |
Why?
|
| Dyspepsia | 1 | 2000 | 106 | 0.010 |
Why?
|
| Vision, Ocular | 1 | 2000 | 116 | 0.010 |
Why?
|
| Nose | 1 | 2000 | 114 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2000 | 145 | 0.010 |
Why?
|
| Testicular Diseases | 1 | 1998 | 12 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 2565 | 0.010 |
Why?
|
| Spermatozoa | 1 | 2000 | 254 | 0.010 |
Why?
|
| Biopsy | 1 | 2000 | 1244 | 0.010 |
Why?
|
| Logistic Models | 1 | 2000 | 1805 | 0.010 |
Why?
|
| Risk Factors | 1 | 2010 | 10978 | 0.010 |
Why?
|
| Incidence | 1 | 2000 | 3336 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1998 | 5199 | 0.000 |
Why?
|
| Prognosis | 1 | 1998 | 4913 | 0.000 |
Why?
|